Outcomes of long term treatments of type I hereditary angioedema in a Turkish family

Akoğlu, GÖKHAN; Kesim, Belgin; Yildiz, Gokhan; Metin, Ahmet

doi:10.1590/abd1806-4841.20175899

Outcomes of long term treatments of type I hereditary angioedema in a Turkish family

Akoğlu G., Kesim B., Yildiz G., Metin A.

ANAIS BRASILEIROS DE DERMATOLOGIA, cilt.92, sa.5, ss.654-659, 2017 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 92 Sayı: 5
Basım Tarihi: 2017
Doi Numarası: 10.1590/abd1806-4841.20175899
Dergi Adı: ANAIS BRASILEIROS DE DERMATOLOGIA
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.654-659
Anahtar Kelimeler: Complement CI inhibitor protein, Danazol, Hereditary Angioedema Types I and II, C1 INHIBITOR GENE, DANAZOL TREATMENT, ATTENUATED ANDROGENS, THROMBOSIS, MUTATION, ATTACKS, PROPHYLAXIS, CONCENTRATE, DEFICIENCY, EDEMA
Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

BACKGROUND: Hereditary angioedema is a rare autosomal dominantly inherited immunodeficiency disorder characterized by potentially life-threatening angioedema attacks.